These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10119189)

  • 61. [Pharmaceutical procedures in patients under treatment with total parenteral nutrition].
    Anoz Jiménez L; Borrás Almenar C; Cavera Rodrigo E
    Farm Hosp; 2004; 28(5):349-55. PubMed ID: 15504092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The economic impact of clinical pharmacists' unsolicited recommendations.
    Torok N; Brown G
    Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cimetidine and parenteral nutrition in the ICU patient.
    Baptista RJ
    Clin Ther; 1986; 8 Suppl A():34-8. PubMed ID: 3098428
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Economics of total parenteral nutrition.
    Goel V
    Nutrition; 1990; 6(4):332-5. PubMed ID: 2134550
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost savings associated with changes in routine laboratory tests ordered for victims of trauma.
    Jacobs IA; Kelly K; Valenziano C; Chevinsky AH; Pawar J; Jones C
    Am Surg; 2000 Jun; 66(6):579-84. PubMed ID: 10888135
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
    Dettmer RM; Riley TH; Byfield F; Green PH
    Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

  • 70. [Pharmacy-managed drug supply may reduce drug expenditure in hospitals].
    Trapnes E; Gløersen E; Mordal K; Refsum N
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1205-6. PubMed ID: 15880162
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inexpensive microcomputer for intravenous admixture service applications.
    Lang JR
    Am J Hosp Pharm; 1983 Mar; 40(3):406-8. PubMed ID: 6846347
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The medical and financial costs associated with termination of a nutrition support nurse.
    Goldstein M; Braitman LE; Levine GM
    JPEN J Parenter Enteral Nutr; 2000; 24(6):323-7. PubMed ID: 11071590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Computer-assisted TPN calculations: time savings and improved accuracy associated with use of a minicomputer.
    Raehtz KG; Walker PC
    Hosp Pharm; 1988 Sep; 23(9):800-4. PubMed ID: 10312684
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Parenteral nutrition program in a major cancer center.
    Muller RJ; Hoffman DM; Mulligan RM
    Hosp Pharm; 1981 Feb; 16(2):54-66. PubMed ID: 10309346
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic implications of growth hormone use in patients with short bowel syndrome.
    Migliaccio-Walle K; Caro JJ; Möller J
    Curr Med Res Opin; 2006 Oct; 22(10):2055-63. PubMed ID: 17022865
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The introduction of a nutrition clinical nurse specialist results in a reduction in the rate of catheter sepsis.
    Sutton CD; Garcea G; Pollard C; Berry DP; Dennison AR
    Clin Nutr; 2005 Apr; 24(2):220-3. PubMed ID: 15784481
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An evaluation of a microcomputer in reducing the preparation time of parenteral nutrition solutions.
    Rich DS; Karnack CM; Jeffrey LP
    JPEN J Parenter Enteral Nutr; 1982; 6(1):71-5. PubMed ID: 6804659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does perioperative total parenteral nutrition reduce medical care costs?
    Eisenberg JM; Glick HA; Buzby GP; Kinosian B; Williford WO
    JPEN J Parenter Enteral Nutr; 1993; 17(3):201-9. PubMed ID: 8505824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pyrogen contamination of total parenteral nutrition solutions: a case report.
    Stansfield SA; Jones EL
    Can J Hosp Pharm; 1983; 36(1):21, 28. PubMed ID: 10310172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.